$63.98
-2.55-3.83%
Last update: Nov 6, 4:00 PM
Inspire Medical Systems Inc
INSPNYSE
Inspire Medical Systems (INSP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Inspire Medical Systems (INSP) last issued guidance on November 2, 2026 for fiscal year 2026. The company guided earnings per share in the range of $1.2 - $1.4, compared to a consensus EPS estimate of $1.25. Inspire Medical Systems also guided revenue in the range of $850M - $860M for the period.
Compared to prior guidance, Inspire Medical Systems raised its EPS outlook from a previous range of $1.05 - $1.45. On the revenue side, the company maintained its revenue forecast from a prior range of $835M - $875M.
Inspire Medical Systems has issued 30 guidance updates between January 9, 2023 and November 2, 2026. During this period, the company raised its outlook 16 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.09 | $-0.24 | $-0.28 | $0.69 |
| Actual | $0.14 | $0.14 | $0.10 | $1.65 |
| Surprise | +55.6% | +158.3% | +135.7% | +139.1% |
| Revenue | ||||
| Estimate | $204.3M | $194.7M | $199.8M | $267.3M |
| Actual | $206.7M | $200.6M | $204.6M | $269.1M |
| Surprise | +1.17% | +3.02% | +2.41% | +0.65% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.28 | $0.14 | $0.19 | $0.38 |
| Revenue | ||||
| Consensus | $204.6M | $201.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $0.14 | $0.09 | 55.6 % |
| Q2 | Aug 3, 2026 | $0.14 | $-0.24 | 158.3 % |
| Q1 | May 4, 2026 | $0.10 | $-0.28 | 135.7 % |
| Q4 | Feb 11, 2026 | $1.65 | $0.69 | 139.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $206.70M | $204.30M | 1.17 % |
| Q2 | Aug 3, 2026 | $200.58M | $194.70M | 3.02 % |
| Q1 | May 4, 2026 | $204.58M | $199.77M | 2.41 % |
| Q4 | Feb 11, 2026 | $269.08M | $267.33M | 0.65 % |
